AU7357996A - Pancreas-derived plasminogen activator inhibitor - Google Patents

Pancreas-derived plasminogen activator inhibitor

Info

Publication number
AU7357996A
AU7357996A AU73579/96A AU7357996A AU7357996A AU 7357996 A AU7357996 A AU 7357996A AU 73579/96 A AU73579/96 A AU 73579/96A AU 7357996 A AU7357996 A AU 7357996A AU 7357996 A AU7357996 A AU 7357996A
Authority
AU
Australia
Prior art keywords
pancreas
plasminogen activator
activator inhibitor
derived plasminogen
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73579/96A
Inventor
Reiner L Gentz
Jian Ni
Steven M. Ruben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU7357996A publication Critical patent/AU7357996A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8132—Plasminogen activator inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU73579/96A 1996-08-16 1996-08-16 Pancreas-derived plasminogen activator inhibitor Abandoned AU7357996A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/013283 WO1998007735A1 (en) 1996-08-16 1996-08-16 Pancreas-derived plasminogen activator inhibitor

Publications (1)

Publication Number Publication Date
AU7357996A true AU7357996A (en) 1998-03-06

Family

ID=22255619

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73579/96A Abandoned AU7357996A (en) 1996-08-16 1996-08-16 Pancreas-derived plasminogen activator inhibitor

Country Status (2)

Country Link
AU (1) AU7357996A (en)
WO (1) WO1998007735A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011786A1 (en) * 1997-09-01 1999-03-11 Otsuka Pharmaceutical Co., Ltd. pancpin GENE AND COMPOSITION FOR GENE THERAPY
ES2526705T3 (en) 2005-10-25 2015-01-14 The Johns Hopkins University Methods and compositions for the treatment of Marfan syndrome and associated disorders
US8454952B2 (en) 2006-03-13 2013-06-04 The Johns Hopkins University Augmentation of endothelial thromboresistance
KR20130131414A (en) 2010-12-27 2013-12-03 엘에스아이피 환도 운에이고우도우가이샤 Ips cells and method for generating same
ES2897740T3 (en) 2011-12-28 2022-03-02 Kyoto Prefectural Public Univ Corp Normalization of corneal endothelial cell culture
PL3064222T3 (en) 2013-10-31 2021-04-19 Kyoto Prefectural Public University Corporation Therapeutic drug comprising tgf-beta signal inhibitor for diseases related to endoplasmic reticulum cell death in corneal endothelium
US10882903B2 (en) 2015-05-18 2021-01-05 Arizona Board Of Regents On Behalf Of The University Of Arizona Methods and compositions for treating an alphavirus infection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923807A (en) * 1984-05-18 1990-05-08 New England Medical Center Hospitals Inc. Arg-Serpin human plasminogen activator inhibitor designated PAI-2
US5470970A (en) * 1991-02-28 1995-11-28 Dana-Farber Cancer Institute, Inc. Maspin, a serpin with tumor suppresing activity

Also Published As

Publication number Publication date
WO1998007735A1 (en) 1998-02-26

Similar Documents

Publication Publication Date Title
AU3832895A (en) Thrombin inhibitors
AU3140695A (en) 1h-indole-1-functional spla2 inhibitors
AU4875196A (en) Novel thrombin inhibitors
AU4787596A (en) Thrombin inhibitors
AU3102397A (en) Metalloprotease inhibitors
AU7497596A (en) Thrombin inhibitors
EP0927035A4 (en) Thrombin inhibitors
AU3941797A (en) Novel thrombin inhibitors
AU1795697A (en) Serine protease inhibitors
AU3877095A (en) Modified proteinase inhibitors
AU1877597A (en) Serine protease inhibitors
AU7139598A (en) Protease inhibitors
AU3459897A (en) Differentiation inhibitor
AU1808999A (en) Fibrinolytic inhibitor for sealant
AU7431796A (en) Brain-associated inhibitor of tissue-type plasminogen activator
AU3396697A (en) Thrombin inhibitor
AU1210797A (en) Cancerous metastasis inhibitor
AU9443898A (en) Wof inhibitor
AU7357996A (en) Pancreas-derived plasminogen activator inhibitor
AU3042697A (en) Thrombin inhibitors
AU9300298A (en) Protease inhibitors
AU6053698A (en) Plasminogen activator as an anti-inflammatory agent
AU4618197A (en) Thrombin inhibitors
AU2908197A (en) Thrombin inhibitors
AU5128298A (en) Metalloproteinase inhibitors